DIA
IPXL

Denver Investment Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Denver Investment Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,889
Closed -$198 – 690
2013
Q4 		$198 Sell
7,889
-1,063
-12% -$23.7K 0.01% 513
2013
Q3 		$190K Sell
8,952
-24,973
-74% -$516K ﹤0.01% 526
2013
Q2 		$680K Buy
+33,925
New +$602K 0.02% 420

Other funds holding IPXL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Denver Investment Advisors's IPXL Position: Q1 2014 in Review

Denver Investment Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q1 2014, closing a stake of 7,889 shares — an estimated $198 sold.

Denver Investment Advisors first reported a position in IPXL in Q2 2013 and held it in 3 quarters. The position peaked at $680K in Q2 2013. 181 funds tracked by Wall St. Rank hold IPXL as of Q1 2014.

  • Denver Investment Advisors reported no remaining Impax Laboratories, Inc. position as of Q1 2014 after selling out during the quarter.
  • Denver Investment Advisors sold 7,889 Impax Laboratories, Inc. shares in Q1 2014, an estimated $198.
  • Denver Investment Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 3 quarters.
  • Denver Investment Advisors's Impax Laboratories, Inc. position peaked at $680K in Q2 2013.
  • 181 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2014.

Based on Denver Investment Advisors's 13F filing for Q1 2014, filed 14 May 2014.